PeatS.Using cannabinoids in pain and palliative care.Int J Palliat Nurs2010; 16(10): 481–485.
2.
OhlssonA., LindgrenJ.E., WahlenA.Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.Clin Pharmacol Ther1980; 28(3): 409–416.
3.
StrougoA., ZuurmanL., RoyC.Modelling of the concentration-effect relationship of THC on central nervous system parameters and heart rate. Insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.J Psychopharmacol2008; 7(22): 717–726.
4.
GrotenhermenF.Pharmacokinetics and pharmacodynamics of cannabinoids.Clin Pharmacokinet2003; 42(4): 327–360.
5.
CooperZ.D., HaneyM.Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.Psychopharmacol2010; 211(2): 141–148.
6.
CarstairsS.D., FujinakaM.K., KeeneyG.E.Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine.J Emerg Med2011; 41(3): e69–e71.
